News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Fresh tissue- Various Cancer Types

Study Status:

Open for enrollment

Contact Information:

(956) 362-2384

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This study is designed to evaluate biomarkers in samples of patients with cancer. In many cases, the investigation is to identify novel markers to create new anti-cancer therapies and companion diagnostics. The biomarkers could be present in plasma, serum, or the tumor tissue itself. In addition, some tumors will be used in a culture environment to determine the efficacy of novel anti-cancer drugs. In addition, some tissues will be mined to isolate, purify, and culture tumor infiltrating lymphocytes, to evaluate immune reactivity in patients.


Principal Investigator
Dr. Sohail Rao
Odalys Salinas
MT Group
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram